Hypofunction of macrophage chemotaxis contributes to defective efficacy of herceptin in HER2-positive breast cancer patients.
Saved in:
| Title: | Hypofunction of macrophage chemotaxis contributes to defective efficacy of herceptin in HER2-positive breast cancer patients. |
|---|---|
| Authors: | Song, Yu1 (AUTHOR) songyugzyx@163.com, Geng, Qiao-Chen1 (AUTHOR), An, Wen-Jing1 (AUTHOR), Zhang, Fu-Cheng1 (AUTHOR), Jiang, Ran1 (AUTHOR), Zhao, Rui-Sheng1 (AUTHOR), Deng, Zhi-Jian1 (AUTHOR), Li, Heng2 (AUTHOR) cpuliheng@gmail.com |
| Source: | Molecular & Cellular Oncology. 2024, Vol. 11 Issue 1, p1-11. 11p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 23723556 |
|---|---|
| DOI: | 10.1080/23723556.2024.2309715 |
